Fiche centre
Hopitaux Universitaires de Strasbourg
Strasbourg — France
Essais liés8clinical trials
VilleStrasbourglocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07164443
Essais cliniques associés
8| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| GNT0004 (1x10e13 vg/kg) | Myopathies | Phase 2/3 | NCT07856329 | A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy | RECRUITING |
| UFOGUIDE "patient transducer" | Cancer | Non applicable | NCT04803773 | UFOGUIDE — MRI-guided Focused Ultrasound : Feasibility Study for the Treatment of Bone Metastases and osteoïd Osteoma | UNKNOWN |
| Pasritamig | Cancer | Phase 3 | NCT07164443 | KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) | RECRUITING |
| EARLY-MG — Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis | Myasthénie | À vérifier | NCT07411963 | EARLY-MG — Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis | RECRUITING |
| Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue | Cancer | Non applicable | NCT03996005 | MRI-TULSAP — MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer | COMPLETED |
| CEREB — Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment | Migraine | Non applicable | NCT07691164 | CEREB — Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment | NOT_YET_RECRUITING |
| DIXI Medical Microdeep® Micro- Macro Depth electrodes | Épilepsie | Non applicable | NCT06105645 | NENUFAR — Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy | RECRUITING |
| Fenebrutinib | SEP | Phase 3 | NCT04544449 | FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |